Paper40559656
A Chemoinformatics Investigation of Spectral and Quantum Chemistry Patterns for Discovering New Drug Leads from Natural Products Targeting the PD-1/PD-L1 Immune Checkpoint, with a Particular Focus on Naturally Occurring Marine Products.
Rabelo H and 3 others. Mar Drugs, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. A Chemoinformatics Investigation of Spectral and Quantum Chemistry Patterns for Discovering New Drug Leads from Natural Products Targeting the PD-1/PD-L1 Immune Checkpoint, with a Particular Focus on Naturally Occurring Marine Products. Papers, record 40559656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40559656
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
A Chemoinformatics Investigation of Spectral and Quantum Chemistry Patterns for Discovering New Drug Leads from Natural Products Targeting the PD-1/PD-L1 Immune Checkpoint, with a Particular Focus on Naturally Occurring Marine Products.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Programmed Cell Death 1 Receptor | Major topic |
| Immune Checkpoint Inhibitors | Major topic |
| B7-H1 Antigen | Major topic |
| Quantitative Structure-Activity Relationship | |
| Molecular Docking Simulation | |
| Humans | |
| Cheminformatics | |
| Machine Learning | |
| Drug Discovery | |
| Aquatic Organisms |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| UIDB/50006/2020 | Fundação para a Ciência e Tecnologia | PubMed | ||
| CEECIND/01649/2021 | Fundação para a Ciência e Tecnologia | PubMed |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34476061 | Predicting chemical shifts with graph neural networks. | Chem Sci | 2021 | https://conductscience.org/library/papers/34476061 | PubMed |
| 2 | 34278794 | AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings. | J Chem Inf Model | 2021 | https://conductscience.org/library/papers/34278794 | PubMed |
| 3 | 34024901 | Relationship of Programmed Death-1 (PD-1) and Programmed Death Ligand-1 (PD-L1) Polymorphisms with Overall Cancer Susceptibility: An Updated Meta-Analysis of 28 Studies with 60 612 Subjects. | Med Sci Monit | 2021 | https://conductscience.org/library/papers/34024901 | PubMed |
| 4 | 30982363 | Have marine natural product drug discovery efforts been productive and how can we improve their efficiency? | Expert Opin Drug Discov | 2019 | https://conductscience.org/library/papers/30982363 | PubMed |
| 5 | 28033004 | Machine Learning Methods to Predict Density Functional Theory B3LYP Energies of HOMO and LUMO Orbitals. | J Chem Inf Model | 2017 | https://conductscience.org/library/papers/28033004 | PubMed |
| 6 | 17956083 | Prediction of 1H NMR coupling constants with associative neural networks trained for chemical shifts. | J Chem Inf Model | 2007 | https://conductscience.org/library/papers/17956083 | PubMed |
| 7 | 34787335 | Prediction of chemical shift in NMR: A review. | Magn Reson Chem | 2022 | https://conductscience.org/library/papers/34787335 | PubMed |
| 8 | 39588778 | COCONUT 2.0: a comprehensive overhaul and curation of the collection of open natural products database. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39588778 | PubMed |
| 9 | 34055224 | Design, Synthesis, and Biological Evaluation of Imidazopyridines as PD-1/PD-L1 Antagonists. | ACS Med Chem Lett | 2021 | https://conductscience.org/library/papers/34055224 | PubMed |
| 10 | 33504104 | The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules. | Molecules | 2021 | https://conductscience.org/library/papers/33504104 | PubMed |
| 11 | 36982981 | Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36982981 | PubMed |
| 12 | 22038946 | Biology-oriented synthesis. | Angew Chem Int Ed Engl | 2011 | https://conductscience.org/library/papers/22038946 | PubMed |
| 13 | 28613862 | Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1. | J Med Chem | 2017 | https://conductscience.org/library/papers/28613862 | PubMed |
| 14 | 30018273 | In Silico HCT116 Human Colon Cancer Cell-Based Models En Route to the Discovery of Lead-Like Anticancer Drugs. | Biomolecules | 2018 | https://conductscience.org/library/papers/30018273 | PubMed |
| 15 | 35450381 | Design, Synthesis, and Evaluation of PD-1/PD-L1 Antagonists Bearing a Benzamide Scaffold. | ACS Med Chem Lett | 2022 | https://conductscience.org/library/papers/35450381 | PubMed |
| 16 | 14632445 | Random forest: a classification and regression tool for compound classification and QSAR modeling. | J Chem Inf Comput Sci | 2003 | https://conductscience.org/library/papers/14632445 | PubMed |
| 17 | 32508653 | Discovering Anti-Cancer Drugs via Computational Methods. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/32508653 | PubMed |
| 18 | 32162523 | Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. | J Nat Prod | 2020 | https://conductscience.org/library/papers/32162523 | PubMed |
| 19 | 15264254 | UCSF Chimera--a visualization system for exploratory research and analysis. | J Comput Chem | 2004 | https://conductscience.org/library/papers/15264254 | PubMed |
| 20 | 30011882 | Computational Methodologies in the Exploration of Marine Natural Product Leads. | Mar Drugs | 2018 | https://conductscience.org/library/papers/30011882 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40559656
GET https://conductscience.org/api/papers/v1/40559656/references?page=2